Clinical Trials List
2023-04-01 - 2026-03-31
Phase I
Recruiting1
Terminated5
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/14
Investigators and Locations
Co-Principal Investigator
- 張育誠 無
- 張義芳 資深主治醫師 Division of Hematology & Oncology
- 林建鴻 主任 Division of Hematology & Oncology
- 張育誠 資深主治醫師 Division of Hematology & Oncology
- 江翊豪 資深主治醫師 Division of Hematology & Oncology
- 林炯森 資深主治醫師 Division of Hematology & Oncology
- 張明志 資深主治醫師 Division of Hematology & Oncology
- 宋孟達 主治醫師 Division of Hematology & Oncology
- 陳功深 主治醫師 Division of Hematology & Oncology
- 陳洛合 主治醫師 Division of Hematology & Oncology
- 蘇迺文 主治醫師 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
42 participants
